100 related articles for article (PubMed ID: 2977786)
1. The monoclonal antibody-defined CAR-3 antigen is a serological marker associated with pancreatic carcinoma.
Prat M; Medico E; Piantino P; Bretti S; Rossini FP; Comoglio PM
Int J Biol Markers; 1988; 3(1):29-35. PubMed ID: 2977786
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated retinopathy syndrome: a case of small cell lung cancer expressing recoverin immunoreactivity.
Matsubara S; Yamaji Y; Fujita T; Kanayama T; Yamadori I; Sato M; Fujita J; Shiotani T; Takahara J
Lung Cancer; 1996 Jun; 14(2-3):265-71. PubMed ID: 8794409
[TBL] [Abstract][Full Text] [Related]
3. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors.
Bazhin AV; Savchenko MS; Shifrina ON; Demoura SA; Chikina SY; Jaques G; Kogan EA; Chuchalin AG; Philippov PP
Lung Cancer; 2004 May; 44(2):193-8. PubMed ID: 15084384
[TBL] [Abstract][Full Text] [Related]
4. CAR-3 and CA 19-9 serum levels in pancreatic cancer: any differences between two epitopes of the same mucin-like glycoprotein?
Meggiato T; Basso D; Fabris C; Fogar P; Panozzo MP; Plebani M; Faggian D; Scalon P; Ferrara C; Del Favero G
Dis Markers; 1990; 8(4):171-7. PubMed ID: 1708317
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines.
Maeda A; Ohguro H; Maeda T; Wada I; Sato N; Kuroki Y; Nakagawa T
Cancer Res; 2000 Apr; 60(7):1914-20. PubMed ID: 10766180
[TBL] [Abstract][Full Text] [Related]
6. Does serum CAR-3 play a role in pancreatic cancer diagnosis?
Basso D; Panozzo MP; Fabris C; Meggiato T; Faggian D; Fogar P; Scalon P; Del Favero G; Plebani M; Burlina A
Oncology; 1991; 48(1):22-5. PubMed ID: 1987495
[TBL] [Abstract][Full Text] [Related]
7. Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy.
Thirkill CE; Keltner JL; Tyler NK; Roth AM
Arch Ophthalmol; 1993 Jul; 111(7):931-7. PubMed ID: 8392327
[TBL] [Abstract][Full Text] [Related]
8. The cancer-associated retinopathy antigen is a recoverin-like protein.
Thirkill CE; Tait RC; Tyler NK; Roth AM; Keltner JL
Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2768-72. PubMed ID: 1388144
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody defines CA 19-9 in pancreatic juices and sera.
Schmiegel WH; Kreiker C; Eberl W; Arndt R; Classen M; Greten H; Jessen K; Kalthoff H; Soehendra N; Thiele HG
Gut; 1985 May; 26(5):456-60. PubMed ID: 3858206
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma.
Salgia R; Hedges TR; Rizk M; Reimer RH; Skarin AT
Lung Cancer; 1998 Nov; 22(2):149-52. PubMed ID: 10022222
[TBL] [Abstract][Full Text] [Related]
11. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.
Ohguro H; Ogawa K; Maeda T; Maruyama I; Maeda A; Takano Y; Nakazawa M
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2589-95. PubMed ID: 11581204
[TBL] [Abstract][Full Text] [Related]
12. Recoverin, but not visinin, is an autoantigen in the human retina identified with a cancer-associated retinopathy.
Polans AS; Burton MD; Haley TL; Crabb JW; Palczewski K
Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):81-90. PubMed ID: 8425844
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic importance of the tumor marker CA 19-9 in pancreatic cancer].
Safi F; Büchler M; Schenkluhn B; Beger HG
Dtsch Med Wochenschr; 1984 Dec; 109(49):1869-73. PubMed ID: 6209082
[TBL] [Abstract][Full Text] [Related]
14. The distribution and localization of the monoclonal antibody-defined antigen 19-9 (CA19-9) in chronic pancreatitis and pancreatic carcinoma. An immunohistochemical study.
Makovitzky J
Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 51(6):535-44. PubMed ID: 2878526
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal cultivation of small-cell carcinoma induces expression of the retinal cancer-associated retinopathy antigen.
Thirkill CE; Tait RC; Tyler NK; Roth AM; Keltner JL
Arch Ophthalmol; 1993 Jul; 111(7):974-8. PubMed ID: 8392328
[TBL] [Abstract][Full Text] [Related]
16. Frequent detection of anti-recoverin cytotoxic T-lymphocyte precursors in peripheral blood of cancer patients by using an HLA-A24-recoverin tetramer.
Rong S; Ikeda H; Sato Y; Hirohashi Y; Takamura Y; Sahara H; Sato T; Maeda A; Ohguro H; Sato N
Cancer Immunol Immunother; 2002 Jul; 51(5):282-90. PubMed ID: 12070715
[TBL] [Abstract][Full Text] [Related]
17. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy.
Ohguro H; Ogawa K; Nakagawa T
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):82-9. PubMed ID: 9888430
[TBL] [Abstract][Full Text] [Related]
18. Significance of adenocarcinoma-associated antigen YH206 levels in the pancreatic juice.
Imai K; Ban T; Endo T; Hinoda Y; Sugiyama T; Hirane T; Yabana T; Hirata K; Wada T; Yachi A
Gastroenterol Jpn; 1990 Feb; 25(1):112-6. PubMed ID: 2407594
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a new tumor-associated antigen in pancreatic cancer.
Savarino V; Mansi C; Pugliese V; Ferrara GB; Arcuri V; Celle G
Digestion; 1984; 29(1):1-4. PubMed ID: 6724164
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated retinopathy.
Thirkill CE; Roth AM; Keltner JL
Arch Ophthalmol; 1987 Mar; 105(3):372-5. PubMed ID: 2950846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
